Issues relating to incentives for life sciences research; H.R. 523/S. 232 (Protect Medical Innovation Act of 2013/Medical Device Access and Innovation Protection Act). Oversight of implementation of the America Invents Act; issues relating to patent settlements, including S. 214 (Preserve Access to Affordable Generics Act); H.R. 3309 (The Innovation Act); S. 1720 (Patent Transparency and Improvements Act of 2013). Issues relating to bioequivalence and related administrative procedures; issues relating to prescription drug abuse; issues relating to incentives for tamper-resistant formulations; H.R. 486 (Stop Tampering of Prescription Pills Act of 2013); issues relating to Medicare Part D rebates; issues relating to health information technology; H.R. 1919 (Safeguarding America's Pharmaceuticals Act of 2013); compounding and drug supply chain legislation; H.R. 3204 (Drug Quality and Security Act); issues relating to products containing high doses of acetaminophen; issues relating to the labeling of generic drugs; issues relating to eliminating Medicare coverage for vacuum erection systems; FDA Proposed Generic Drug Labeling Rule. Issues related to tamper resistant formulation of pharmaceutical drugs; Life Sciences Jobs and Investment Act.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ENDO INTERNATIONAL
1400 Atwater Drive, Malvern, PA, 19355, US
JAMES BRIAN MUNROE ANDREW SCOTT JAMES BRIAN MUNROE ANDREW SCOTT JAMES BRIAN MUNROE ANDREW SCOTT JAMES BRIAN MUNROE ANDREW SCOTT